Helius Medical Technologies Inc Class A Cash Flow Conversion Efficiency
Helius Medical Technologies Inc Class A cash flow conversion efficiency. Based on the latest financial reports, Helius Medical Technologies Inc Class A (HSDT) has a cash flow conversion efficiency ratio of 0.027x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-4.04 Million) by net assets ($-152.39 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Helius Medical Technologies Inc Class A (2013–2024)
Cash flow conversion efficiency of Helius Medical Technologies Inc Class A from 2013 to 2024. This chart illustrates how Helius Medical Technologies Inc Class A's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Helius Medical Technologies Inc Class A stock quote for real-time trading data and today's change.
Helius Medical Technologies Inc Class A Cash Flow Conversion Ratio Explained
Helius Medical Technologies Inc Class A cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Helius Medical Technologies Inc Class A Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Helius Medical Technologies Inc Class A ranked by their cash flow conversion efficiency. Also see HSDT market cap overview for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Mirae Asset Daewoo Special Purpose Acquisition Company 3 Co. Ltd
KQ:328380
|
0.045x |
|
Euroapi SAS
PA:EAPI
|
-0.139x |
|
ATHOS IMMO (IJM.SG)
STU:IJM
|
N/A |
|
The Naga Group AG
XETRA:N4G
|
0.002x |
|
ST Dupont
PA:DPT
|
-0.078x |
|
Ba Ria Vung Tau House Development JSC
VN:HDC
|
-0.001x |
|
IokCompany Co. Ltd
KQ:078860
|
0.010x |
|
ShareHope Medicine Co Ltd
TWO:8403
|
0.030x |
Annual Cash Flow Conversion Efficiency for Helius Medical Technologies Inc Class A (2013–2024)
The table below shows the annual cash flow conversion efficiency of Helius Medical Technologies Inc Class A from 2013 to 2024. Review HSDT free cash flow to operating cash ratio to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $1.06 Million | $-11.04 Million | -10.426x | -135.22% |
| 2023-12-31 | $2.35 Million | $-10.42 Million | -4.432x | -152.47% |
| 2022-12-31 | $8.15 Million | $-14.31 Million | -1.756x | -47.60% |
| 2021-12-31 | $11.26 Million | $-13.39 Million | -1.189x | +60.78% |
| 2020-12-31 | $3.87 Million | $-11.74 Million | -3.032x | +15.74% |
| 2019-12-31 | $5.83 Million | $-21.00 Million | -3.599x | -80.74% |
| 2018-12-31 | $9.85 Million | $-19.62 Million | -1.991x | -177.17% |
| 2017-12-31 | $-7.49 Million | $-19.32 Million | 2.580x | -99.47% |
| 2016-12-31 | $-16.19K | $-7.94 Million | 490.176x | -0.01% |
| 2015-12-31 | $-16.19K | $-7.94 Million | 490.206x | +12020.05% |
| 2014-12-31 | $-1.56 Million | $-6.32 Million | 4.045x | +210.83% |
| 2013-12-31 | $-267.98K | $-348.70K | 1.301x | -- |
About Helius Medical Technologies Inc Class A
Solana Company operates as a listed digital asset treasury. It enhances SOL per share on the commercially viable blockchain for decentralized finance and consumer applications. The company is headquartered in Newtown, Pennsylvania.